tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RZLT Stock Latest News

Rezolute price target lowered to $4 from $20 at Maxim
The FlyRezolute price target lowered to $4 from $20 at Maxim
13d ago
RZLT
Rezolute price target lowered to $6 from $15 at Guggenheim
PremiumThe Fly
Rezolute price target lowered to $6 from $15 at Guggenheim
13d ago
RZLT
Rezolute price target lowered to $5 from $14 at H.C. Wainwright
PremiumThe Fly
Rezolute price target lowered to $5 from $14 at H.C. Wainwright
13d ago
RZLT
Rezolute downgraded to Hold from Buy at Craig-Hallum
PremiumThe Fly
Rezolute downgraded to Hold from Buy at Craig-Hallum
13d ago
RZLT
Rezolute price target lowered to $5 from $17 at BTIG
PremiumThe Fly
Rezolute price target lowered to $5 from $17 at BTIG
14d ago
RZLT
Rezolute downgraded to Market Perform from Outperform at Citizens
PremiumThe FlyRezolute downgraded to Market Perform from Outperform at Citizens
14d ago
RZLT
Rezolute downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Rezolute downgraded to Neutral from Overweight at Cantor Fitzgerald
14d ago
RZLT
Wedbush downgrades Rezolute to Neutral after congenital hyperinsulinism miss
Premium
The Fly
Wedbush downgrades Rezolute to Neutral after congenital hyperinsulinism miss
14d ago
RZLT
Rezolute Downgraded to Hold Amid Disappointing Phase 3 Trial Results for Ersodetug
PremiumRatings
Rezolute Downgraded to Hold Amid Disappointing Phase 3 Trial Results for Ersodetug
14d ago
RZLT
Rezolute downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Rezolute downgraded to Neutral from Outperform at Wedbush
14d ago
RZLT
Xoma price target lowered to $45 from $58 at Leerink
PremiumThe Fly
Xoma price target lowered to $45 from $58 at Leerink
14d ago
RZLT
XOMA
Rezolute Inc trading resumes
PremiumThe Fly
Rezolute Inc trading resumes
14d ago
RZLT
Rezolute Inc trading halted, volatility trading pause
PremiumThe FlyRezolute Inc trading halted, volatility trading pause
14d ago
RZLT
Xoma falls 21% after partner Rezolute announces trial failure
Premium
The Fly
Xoma falls 21% after partner Rezolute announces trial failure
14d ago
RZLT
XOMA
Rezolute down 88% at $1.27 in pre-market after ersodetug Phase 3 study data
Premium
The Fly
Rezolute down 88% at $1.27 in pre-market after ersodetug Phase 3 study data
14d ago
RZLT
Rezolute’s Phase 3 study in congenital hyperinsulinism did not meet endpoints
PremiumThe Fly
Rezolute’s Phase 3 study in congenital hyperinsulinism did not meet endpoints
14d ago
RZLT
Rezolute files automatic mixed securities shelf
PremiumThe Fly
Rezolute files automatic mixed securities shelf
19d ago
RZLT
Rezolute price target raised to $20 from $15 at Jefferies
PremiumThe Fly
Rezolute price target raised to $20 from $15 at Jefferies
19d ago
RZLT
Rezolute Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Rezolute Approves Key Proposals at Annual Meeting
1M ago
8K
RZLT
Promising Potential of Rezolute’s Ersodetug in Treating Congenital Hyperinsulinism Drives Buy Rating
PremiumRatingsPromising Potential of Rezolute’s Ersodetug in Treating Congenital Hyperinsulinism Drives Buy Rating
1M ago
RZLT
Rezolute’s Promising Future: Buy Rating Backed by Strong Financials and Strategic Market Expansion
Premium
Ratings
Rezolute’s Promising Future: Buy Rating Backed by Strong Financials and Strategic Market Expansion
1M ago
RZLT
Rezolute’s Promising Growth Potential: Buy Rating Backed by Strong Market Prospects for Ersodetug
Premium
Ratings
Rezolute’s Promising Growth Potential: Buy Rating Backed by Strong Market Prospects for Ersodetug
1M ago
RZLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >